In the past week, CVS stock has gone down by -5.63%, with a monthly decline of -2.46% and a quarterly plunge of -8.94%. The volatility ratio for the week is 2.68%, and the volatility levels for the last 30 days are 2.03% for CVS Health Corporation The simple moving average for the last 20 days is -2.71% for CVS’s stock, with a simple moving average of -21.70% for the last 200 days.
Is It Worth Investing in CVS Health Corporation (NYSE: CVS) Right Now?
CVS Health Corporation (NYSE: CVS) has a price-to-earnings ratio that is above its average at 22.31x. and a 36-month beta value of 0.61. Opinions on the stock are mixed, with 16 analysts rating it as a “buy,” 2 as “overweight,” 8 as “hold,” and 0 as “sell.”
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
The average price predicted for CVS Health Corporation (CVS) by analysts is $97.28, which is $30.46 above the current market price. The public float for CVS is 1.28B, and at present, short sellers hold a 1.17% of that float. On June 20, 2023, the average trading volume of CVS was 8.52M shares.
CVS) stock’s latest price update
CVS Health Corporation (NYSE: CVS)’s stock price has dropped by -2.56 in relation to previous closing price of 69.50. Nevertheless, the company has seen a loss of -5.63% in its stock price over the last five trading days. Barrons Online reported on 06/14/23 that UnitedHealth and Humana Stocks Fall as Seniors Catch Up on Surgeries, Leading to Higher Costs
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Piper Sandler repeating the rating for CVS by listing it as a “Overweight.” The predicted price for CVS in the upcoming period, according to Piper Sandler is $85 based on the research report published on May 26th of the current year 2023.
CVS Trading at -5.17% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.86% of loss for the given period.
Volatility was left at 2.03%, however, over the last 30 days, the volatility rate increased by 2.68%, as shares sank -2.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.90% lower at present.
During the last 5 trading sessions, CVS fell by -5.63%, which changed the moving average for the period of 200-days by -31.46% in comparison to the 20-day moving average, which settled at $69.53. In addition, CVS Health Corporation saw -27.33% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from Lynch Karen S, who purchase 14,000 shares at the price of $69.75 back on May 03. After this action, Lynch Karen S now owns 431,392 shares of CVS Health Corporation, valued at $976,567 using the latest closing price.
Moriarty Thomas M, the EVP & General Counsel of CVS Health Corporation, sale 137,466 shares at $98.36 during a trade that took place back on Dec 15, which means that Moriarty Thomas M is holding 608,129 shares at $13,521,180 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- +5.08 for the present operating margin
- +16.92 for the gross margin
The net margin for CVS Health Corporation stands at +1.29. The total capital return value is set at 11.18, while invested capital returns managed to touch 2.93. Equity return is now at value 5.50, with 1.70 for asset returns.
Based on CVS Health Corporation (CVS), the company’s capital structure generated 99.60 points at debt to equity in total, while total debt to capital is 49.90. Total debt to assets is 29.94, with long-term debt to equity ratio resting at 94.73. Finally, the long-term debt to capital ratio is 47.46.
When we switch over and look at the enterprise to sales, we see a ratio of 0.43, with the company’s debt to enterprise value settled at 0.40. The receivables turnover for the company is 12.49 and the total asset turnover is 1.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
To sum up, CVS Health Corporation (CVS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.